<DOC>
	<DOC>NCT01632137</DOC>
	<brief_summary>The purpose of this study is to evaluate the efficacy and safety of rebamipide ophthalmic suspension in subjects with dry eye syndrome.</brief_summary>
	<brief_title>Efficacy and Safety of Rebamipide in Subjects With Dry Eye Syndrome</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Keratoconjunctivitis Sicca</mesh_term>
	<mesh_term>Dry Eye Syndromes</mesh_term>
	<mesh_term>Rebamipide</mesh_term>
	<criteria>History of dry eyerelated ocular symptoms for at least 20 months. Meet protocoldefined criteria for corneal and conjunctival staining. Meet protocoldefined criteria for ocular discomfort. Active anterior segment ocular disease other than dry eye syndrome. Inability to suspend the use of topical ophthalmic medications throughout the duration of the study. Inability to suspend the use of contact lenses for the duration of the study. Judged by the investigator to be ineligible for the study because of a past or concurrent systemic disease, or safety concerns. Received any other investigational product within 4 months before the screening visit.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2014</verification_date>
</DOC>